Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with rituximab-CHOP: a report from an International DLBCL Rituximab-CHOP Consortium Program study

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

    Zijun Y Xu-Monette, Lin Wu, Carlo Visco, Yu Chuan Tai, Alexander Tzankov, Wei-Min Liu, Santiago Montes-Moreno, Karen Dybkær, DenmarkApril Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L Richards, Eric D Hsi, X Frank Zhao, William Wl Choi, Xiaoying Zhao, J Han van Krieken, Qin Huang, Jooryung Huh, Weiyun Ai, Maurilio A Ponzoni, Andres Jm Ferreri, Fan Zhou, Brad S Kahl, Jane N Winter, Wei Xu, Jianyong Li, Ronald S Go, Yong Li, Miguel A Piris, Michael B Møller, Roberto N Miranda, Lynne V Abruzzo, L Jeffrey Medeiros, Ken H Young
Original languageEnglish
Issue number19
Pages (from-to)3986-3996
Number of pages11
Publication statusPublished - 2012

See relations at Aarhus University Citationformats

ID: 48623809